Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · GE HealthCare (GEHC)

GE HealthCare Q3 revenue rises 6% to $5.1 billion; adjusted EPS falls to $1.07

Mixed Impact 4 of 5 earnings Written later

GE HealthCare reported third quarter 2025 revenue of $5.1 billion, up 6% from a year earlier, but adjusted earnings per share fell to $1.07 from $1.14 as tariffs weighed on profit. The company raised the lower end of its full-year 2025 adjusted EPS guidance to $4.51 from $4.43 and reaffirmed its other targets.

Key points

  • Revenue of $5.1 billion rose 6% reported and 4% organic year over year; total company orders grew 6% organically.
  • Net income attributable to GE HealthCare was $446 million versus $470 million; diluted EPS was $0.98 versus $1.02.
  • Adjusted EPS was $1.07 versus $1.14; the company said tariffs hurt margin and EPS, and would have exceeded prior year without them.
  • Full-year 2025 adjusted EPS guidance is $4.51 to $4.63, including about $0.45 of tariff impact; free cash flow for the quarter was $483 million versus $651 million.

The filing

CompanyGE HealthCare (GEHC)
Form8-K, current report
Filed with the SECOct 29, 2025, 6:25 AM ET
Accession number0001932393-25-000052

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.